352
+0.57%
Close of 9 Nov 2026, in IDR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Kimia Farma Tbk PT
Its shares trade on IDX under the ticker KAEF.JK. It has been listed since 4 July 2001. In the fiscal year to 31 December 2025, it reported revenue of IDR 9.22trn and a net loss of IDR 334.96bn. At that date it held total assets of IDR 14.18trn and shareholders' equity of IDR 2.66trn.
PT Kimia Farma Tbk engages in the production and distribution of healthcare products. The company is headquartered in Jakarta, Dki Jakarta. The company went IPO on 2001-07-04. Its segments include Manufacturing, Distribution, Retail, and Other. The Manufacturing segment includes chemical and pharmaceutical manufacturing, research and development, and manufacturing marketing and marketing of quinine and essential oils; manufacturing and marketing of active pharmaceutical ingredients and HFC, and manufacturing and marketing of pharmaceutical products. The distribution segment is engaged in distribution of pharmaceutical products to domestic market and to the international market, including Saudi Arabia, the United States, Netherlands, the United Kingdom, China, Malaysia, and several other countries. The Retail segment is engaged in the sale of medicines and pharmaceutical products directly to customers.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 4 Jul 2001
- Employees
- 11,560
- Website
- kimiafarma.co.id ↗
Leadership
Pay as last reported
- Prof. Dr. Abdul KadirPresident Commissioner
- Drs. Verdi BudidarmoPresident Director
- Ir. Lina SariFinance and Risk Management Director
- Drs. Imam FathorrahmanMarketing and Commercial Director
- Mr. Dharma SyahputraGeneral Affair and Human Capital Director
- Ms. Jasmine KarsonoPortfolio and Business Development Director
- Drs. Andi PrazosProduction and Supply Chain Director
- Mr. Ganti Winarno PutroCorporate Secretary
- Mr. Dwi Ary PurnomoCommissioner
- Dr. Subandi SardjokoCommissioner
- Dr. Kamelia FaisalIndependent Commissioner
- Dr. Musthofa FauziIndependent Commissioner
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- PT Kimia Farma Tbk employs 11,560 full-time staff members across its operations.
- The Manufacturing segment produces quinine and essential oils for global markets.
- Active pharmaceutical ingredients are manufactured and marketed by the company effectively.
Weaknesses
- The company is headquartered in Jakarta, Dki Jakarta, which may limit local agility.
- IPO occurred on 4 July 2001, meaning the firm has operated for over two decades.
- The Retail segment sells medicines directly to customers, requiring significant logistical support.
Opportunities
- Distribution to Saudi Arabia offers potential growth in the Middle Eastern market.
- Expanding distribution to the United States can increase international revenue streams.
- Sales in the Netherlands and the United Kingdom provide entry to European markets.
Threats
- Distribution to China faces intense competition from local pharmaceutical manufacturers.
- Market entry into Malaysia requires navigating complex regional regulatory frameworks.
- International distribution to multiple countries increases operational complexity and costs.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.